| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |